• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

入院时轻度疾病患者的血小板计数与进展为严重汉坦病毒心肺综合征相关。

Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.

机构信息

Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago 7650567, Chile.

Escuela de Medicina. Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago 7710162, Chile.

出版信息

Viruses. 2019 Jul 30;11(8):693. doi: 10.3390/v11080693.

DOI:10.3390/v11080693
PMID:31366116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6724000/
Abstract

BACKGROUND

Hantavirus cardiopulmonary syndrome (HCPS) has a mortality up to 35-40% and its treatment is mainly supportive. A variable to predict progression from mild to severe disease is unavailable. This study was performed in patients with documented infection by Andes orthohantavirus, and the aim was to find a simple variable to predict progression to moderate/severe HCPS in patients with mild disease at admission.

METHODS

We performed a retrospective analysis of 175 patients between 2001 and 2018. Patients were categorized into mild, moderate, and severe disease according to organ failure and advanced support need at hospital admission (e.g., mechanical ventilation, vasopressors). Progression to moderate/severe disease was defined accordingly. Clinical and laboratory variables associated with progression were explored.

RESULTS

Forty patients with mild disease were identified; 14 of them progressed to moderate/severe disease. Only platelet count was different between those who progressed versus those that did not (37 (34-58) vs. 83 (64-177) K/mm, < 0.001). A ROC curve analysis showed an AUC = 0.889 (0.78-1.0) < 0.001, with a platelet count greater than 115K /mm ruling out progression to moderate/severe disease.

CONCLUSIONS

In patients with mild disease at presentation, platelet count could help to define priority of evacuation to tertiary care centers.

摘要

背景

汉坦病毒心肺综合征(HCPS)的死亡率高达 35-40%,其治疗主要为支持性治疗。目前还没有可以预测轻症向重症进展的指标。本研究纳入了已确诊感染安第斯 orthohantavirus 的患者,旨在寻找一种简单的变量,以预测轻症患者入院时病情进展为中/重度 HCPS。

方法

我们对 2001 年至 2018 年间的 175 例患者进行了回顾性分析。根据入院时器官衰竭和高级支持需求(例如机械通气、升压药),将患者分为轻症、中症和重症。相应地将进展到中/重度疾病定义为进展。探讨与疾病进展相关的临床和实验室变量。

结果

确定了 40 例轻症患者,其中 14 例进展为中/重度疾病。仅血小板计数在进展组和未进展组之间存在差异(37(34-58) vs. 83(64-177) K/mm, < 0.001)。ROC 曲线分析显示 AUC = 0.889(0.78-1.0) < 0.001,血小板计数大于 115 K /mm 可排除进展为中/重度疾病。

结论

在入院时表现为轻症的患者中,血小板计数有助于确定向三级护理中心转移的优先级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feee/6724000/e5be160cdcec/viruses-11-00693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feee/6724000/e5be160cdcec/viruses-11-00693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/feee/6724000/e5be160cdcec/viruses-11-00693-g001.jpg

相似文献

1
Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome.入院时轻度疾病患者的血小板计数与进展为严重汉坦病毒心肺综合征相关。
Viruses. 2019 Jul 30;11(8):693. doi: 10.3390/v11080693.
2
[Clinical laboratory criteria and its utility as predictive of diagnosis of the cardiopulmonary syndrome by hantavirus].[汉坦病毒心肺综合征诊断的临床实验室标准及其预测效用]
Rev Chilena Infectol. 2019 Jun;36(3):299-303. doi: 10.4067/S0716-10182019000300299.
3
Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients.血小板减少症与炎症的严重程度以及反映普马拉汉坦病毒感染毛细血管渗漏的变量相关,对 546 例芬兰患者的分析。
Infect Dis (Lond). 2016 Sep;48(9):682-7. doi: 10.1080/23744235.2016.1192719. Epub 2016 Jun 14.
4
Humoral immune responses in the hantavirus cardiopulmonary syndrome.汉坦病毒心肺综合征中的体液免疫反应。
J Infect Dis. 2000 Jul;182(1):43-8. doi: 10.1086/315657. Epub 2000 Jun 27.
5
High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial.智利汉坦病毒心肺综合征的大剂量静脉注射甲基强的松龙:一项双盲、随机对照临床试验。
Clin Infect Dis. 2013 Oct;57(7):943-51. doi: 10.1093/cid/cit394. Epub 2013 Jun 19.
6
Longitudinal Assessment of Cytokine Expression and Plasminogen Activation in Hantavirus Cardiopulmonary Syndrome Reveals Immune Regulatory Dysfunction in End-Stage Disease.汉坦病毒心肺综合征中细胞因子表达和纤溶酶原激活的纵向评估显示终末期疾病免疫调节功能障碍。
Viruses. 2021 Aug 12;13(8):1597. doi: 10.3390/v13081597.
7
Hantavirus Disease and COVID-19.汉坦病毒病与 COVID-19。
Am J Clin Pathol. 2022 Mar 3;157(3):470-475. doi: 10.1093/ajcp/aqab155.
8
Proteinuria in Hantavirus Cardiopulmonary Syndrome: A Frequent Finding Linked To Mortality.汉坦病毒心肺综合征中的蛋白尿:一种与死亡率相关的常见发现。
Int J Infect Dis. 2021 Sep;110:466-468. doi: 10.1016/j.ijid.2021.07.026. Epub 2021 Jul 13.
9
Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker.评估汉坦病毒心肺综合征中的肺上皮细胞损伤:sRAGE 作为一种潜在的生物标志物,挑战血管内皮细胞的主要作用。
Viruses. 2023 Sep 26;15(10):1995. doi: 10.3390/v15101995.
10
[Prognostic factors for cardio-pulmonary syndrome and death by hantavirus Andes Sur: cohort study in San Carlos de Bariloche and health influence area].[安第斯南部汉坦病毒所致心肺综合征及死亡的预后因素:巴里洛切圣卡洛斯及健康影响区域的队列研究]
Medicina (B Aires). 2022;82(3):351-360.

引用本文的文献

1
Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.普马拉正汉坦病毒:流行情况、生物学特性、疾病、动物模型以及治疗学开发与结构生物学的最新进展
Front Immunol. 2025 May 8;16:1575112. doi: 10.3389/fimmu.2025.1575112. eCollection 2025.
2
Levels of peripheral blood routine, biochemical and coagulation parameters in patients with hemorrhagic fever with renal syndrome and their relationship with prognosis: an observational cohort study.出血热伴肾综合征患者外周血常规、生化和凝血参数水平及其与预后的关系:一项观察性队列研究。
BMC Infect Dis. 2024 Jan 11;24(1):75. doi: 10.1186/s12879-023-08777-w.
3

本文引用的文献

1
Platelet Distribution Width at First Day of Hospital Admission in Patients with Hemorrhagic Fever with Renal Syndrome Caused by Hantaan Virus May Predict Disease Severity and Critical Patients' Survival.入院第 1 天血小板分布宽度可预测汉坦病毒致肾综合征出血热患者的疾病严重程度和危重症患者的生存。
Dis Markers. 2018 Jun 19;2018:9701619. doi: 10.1155/2018/9701619. eCollection 2018.
2
Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV).病毒分类学:国际病毒分类委员会(ICTV)数据库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D708-D717. doi: 10.1093/nar/gkx932.
3
[Correlation between clinical and laboratory criteria of suspected Hantavirus cases and the results of the reference diagnostic technique].
Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker.
评估汉坦病毒心肺综合征中的肺上皮细胞损伤:sRAGE 作为一种潜在的生物标志物,挑战血管内皮细胞的主要作用。
Viruses. 2023 Sep 26;15(10):1995. doi: 10.3390/v15101995.
4
Sepsis - it is all about the platelets.败血症——关键在于血小板。
Front Immunol. 2023 Jun 7;14:1210219. doi: 10.3389/fimmu.2023.1210219. eCollection 2023.
5
Recent Developments in NSG and NRG Humanized Mouse Models for Their Use in Viral and Immune Research.新型 NSG 和 NRG 人源化小鼠模型在病毒和免疫研究中的最新进展。
Viruses. 2023 Feb 9;15(2):478. doi: 10.3390/v15020478.
6
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and .基于卡介苗的疫苗引发针对严重急性呼吸综合征冠状病毒2的抗原特异性适应性免疫和训练有素的免疫反应。 (你提供的原文似乎不完整,最后的“and.”不知具体内容,以上翻译是基于现有完整部分。)
Vaccines (Basel). 2022 May 4;10(5):721. doi: 10.3390/vaccines10050721.
7
miR-486-5p Serves as a Diagnostic Biomarker for Sepsis and Its Predictive Value for Clinical Outcomes.miR-486-5p作为脓毒症的诊断生物标志物及其对临床结局的预测价值。
J Inflamm Res. 2021 Jul 30;14:3687-3695. doi: 10.2147/JIR.S323433. eCollection 2021.
[疑似汉坦病毒病例的临床与实验室标准与参考诊断技术结果之间的相关性]
Rev Chilena Infectol. 2016 Jun;33(3):275-81. doi: 10.4067/S0716-10182016000300004.
4
Thrombocytopenia associates with the severity of inflammation and variables reflecting capillary leakage in Puumala Hantavirus infection, an analysis of 546 Finnish patients.血小板减少症与炎症的严重程度以及反映普马拉汉坦病毒感染毛细血管渗漏的变量相关,对 546 例芬兰患者的分析。
Infect Dis (Lond). 2016 Sep;48(9):682-7. doi: 10.1080/23744235.2016.1192719. Epub 2016 Jun 14.
5
Molecular method for the detection of Andes hantavirus infection: validation for clinical diagnostics.检测安第斯汉坦病毒感染的分子方法:临床诊断验证
Diagn Microbiol Infect Dis. 2016 Jan;84(1):36-39. doi: 10.1016/j.diagmicrobio.2015.07.019. Epub 2015 Jul 29.
6
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients.汉坦病毒感染患者的血小板生成增加和血小板活化。
J Infect Dis. 2015 Oct 1;212(7):1061-9. doi: 10.1093/infdis/jiv161. Epub 2015 Mar 11.
7
A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus.一项关于人免疫血浆治疗安第斯病毒引起的汉坦病毒心肺综合征的非随机多中心试验。
Antivir Ther. 2015;20(4):377-86. doi: 10.3851/IMP2875. Epub 2014 Oct 15.
8
Person-to-person household and nosocomial transmission of andes hantavirus, Southern Chile, 2011.2011年,智利南部安第斯汉坦病毒的家庭内人际传播及医院感染传播
Emerg Infect Dis. 2014 Oct;20(10):1629-36. doi: 10.3201/eid2010.140353.
9
Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology.人类汉坦病毒感染:流行病学、临床特征、发病机制和免疫学。
Swiss Med Wkly. 2014 Mar 20;144:w13937. doi: 10.4414/smw.2014.13937.
10
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012.2012年美国加利福尼亚州优胜美地国家公园过夜游客中的汉坦病毒感染情况。
Emerg Infect Dis. 2014 Mar;20(3):386-93. doi: 10.3201/eid2003.131581.